Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Active Not Recruiting Phase 1 Trials for Busulfan (DB01008)

IndicationStatusPhase
DBCOND0029297 (Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00638898Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorTreatment